AVAX Technologies, Inc. (AVXT)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2007 | -6.41 Million USD | -19.76% |
| 2006 | -5.35 Million USD | -44.6% |
| 2005 | -3.7 Million USD | -7.11% |
| 2004 | -3.45 Million USD | -5.23% |
| 2003 | -3.28 Million USD | 65.14% |
| 2002 | -9.42 Million USD | 37.62% |
| 2001 | -15.1 Million USD | 7.17% |
| 2000 | -16.27 Million USD | -106.03% |
| 1999 | -7.9 Million USD | -36.21% |
| 1998 | -5.8 Million USD | -34.88% |
| 1997 | -4.3 Million USD | -186.67% |
| 1996 | -1.5 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2008 Q2 | -1.87 Million USD | 3.11% |
| 2008 Q1 | -1.93 Million USD | -13.74% |
| 2008 Q3 | -1.87 Million USD | 0.1% |
| 2007 FY | -6.41 Million USD | -19.76% |
| 2007 Q1 | -1.32 Million USD | 4.96% |
| 2007 Q2 | -1.52 Million USD | -14.77% |
| 2007 Q3 | -1.86 Million USD | -22.65% |
| 2007 Q4 | -1.69 Million USD | 8.91% |
| 2006 Q1 | -1.31 Million USD | 2.6% |
| 2006 Q3 | -1.37 Million USD | -7.4% |
| 2006 FY | -5.35 Million USD | -44.6% |
| 2006 Q4 | -1.39 Million USD | -1.74% |
| 2006 Q2 | -1.27 Million USD | 2.73% |
| 2005 Q3 | -566.85 Thousand USD | 55.39% |
| 2005 Q2 | -1.27 Million USD | -144.99% |
| 2005 FY | -3.7 Million USD | -7.11% |
| 2005 Q1 | -518.67 Thousand USD | 33.03% |
| 2005 Q4 | -1.34 Million USD | -137.71% |
| 2004 Q1 | -1.08 Million USD | 24.26% |
| 2004 Q4 | -774.48 Thousand USD | 9.83% |
| 2004 Q3 | -858.93 Thousand USD | -15.62% |
| 2004 Q2 | -742.88 Thousand USD | 31.32% |
| 2004 FY | -3.45 Million USD | -5.23% |
| 2003 Q1 | -1.1 Million USD | 59.28% |
| 2003 FY | -3.28 Million USD | 65.14% |
| 2003 Q3 | -781.04 Thousand USD | -2943.35% |
| 2003 Q4 | -1.42 Million USD | -82.84% |
| 2003 Q2 | 27.46 Thousand USD | 102.49% |
| 2002 Q4 | -2.71 Million USD | -4.32% |
| 2002 FY | -9.42 Million USD | 37.62% |
| 2002 Q1 | -1.49 Million USD | 76.07% |
| 2002 Q3 | -2.59 Million USD | 0.55% |
| 2002 Q2 | -2.61 Million USD | -74.43% |
| 2001 Q4 | -6.26 Million USD | -104.6% |
| 2001 Q3 | -3.06 Million USD | -20.61% |
| 2001 Q2 | -2.53 Million USD | 21.86% |
| 2001 FY | -15.1 Million USD | 7.17% |
| 2001 Q1 | -3.24 Million USD | 47.32% |
| 2000 Q3 | -5.45 Million USD | -128.63% |
| 2000 Q4 | -6.16 Million USD | -12.98% |
| 2000 FY | -16.27 Million USD | -106.03% |
| 2000 Q2 | -2.38 Million USD | -5.3% |
| 2000 Q1 | -2.26 Million USD | 5.55% |
| 1999 Q2 | -1.9 Million USD | -18.75% |
| 1999 Q3 | -2 Million USD | -5.26% |
| 1999 Q1 | -1.6 Million USD | -14.29% |
| 1999 Q4 | -2.4 Million USD | -20.0% |
| 1999 FY | -7.9 Million USD | -36.21% |
| 1998 Q1 | -1.4 Million USD | 0.0% |
| 1998 FY | -5.8 Million USD | -34.88% |
| 1998 Q4 | -1.4 Million USD | 0.0% |
| 1998 Q3 | -1.4 Million USD | 12.5% |
| 1998 Q2 | -1.6 Million USD | -14.29% |
| 1997 Q2 | -1.1 Million USD | -10.0% |
| 1997 Q3 | -800 Thousand USD | 27.27% |
| 1997 FY | -4.3 Million USD | -186.67% |
| 1997 Q4 | -1.4 Million USD | -75.0% |
| 1997 Q1 | -1 Million USD | 0.0% |
| 1996 FY | -1.5 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | -1.33 Million USD | -380.268% |
| Arch Therapeutics, Inc. | -6.98 Million USD | 8.151% |
| Evofem Biosciences, Inc. | 52.97 Million USD | 112.106% |
| Nascent Biotech, Inc. | -2.08 Million USD | -207.214% |
| Rebus Holdings, Inc. | -1.02 Million USD | -528.789% |
| Santhera Pharmaceuticals Holding AG | 65.13 Million USD | 109.847% |
| Qrons Inc. | -789.34 Thousand USD | -712.526% |
| Adynxx, Inc. | - USD | Infinity% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -914.165% |
| Northwest Biotherapeutics, Inc. | -62.59 Million USD | 89.754% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -1443.676% |
| Skye Bioscience, Inc. | -37.64 Million USD | 82.963% |
| Eiger BioPharmaceuticals, Inc. | -74.96 Million USD | 91.444% |
| Nanobac Pharmaceuticals, Incorporated | -6.57 Million USD | 2.471% |
| Institute of Biomedical Research Corp. | -273.4 Thousand USD | -2245.867% |
| SQZ Biotechnologies Company | -79.46 Million USD | 91.929% |
| Intellipharmaceutics International Inc. | -2.89 Million USD | -121.742% |
| Propanc Biopharma, Inc. | -1.82 Million USD | -252.296% |
| Mesoblast Limited | -87.95 Million USD | 92.708% |
| Marizyme, Inc. | -65.34 Million USD | 90.185% |
| Genus plc | 7.9 Million USD | 181.185% |
| VioQuest Pharmaceuticals, Inc. | -10.89 Million USD | 41.115% |
| Pharming Group N.V. | -10.54 Million USD | 39.196% |
| Therapeutic Solutions International, Inc. | -2.16 Million USD | -195.585% |
| CNBX Pharmaceuticals Inc. | -3.71 Million USD | -72.864% |
| Nymox Pharmaceutical Corporation | -8.84 Million USD | 27.48% |
| ContraFect Corporation | -65.15 Million USD | 90.156% |
| PsyBio Therapeutics Corp. | -4.88 Million USD | -31.264% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.72 Million USD | -271.277% |
| IMV Inc. | -36.48 Million USD | 82.421% |
| AXIM Biotechnologies, Inc. | -8.05 Million USD | 20.423% |
| MultiCell Technologies, Inc. | -380.07 USD | -1687391.252% |
| ONE Bio Corp. | 8.67 Million USD | 173.919% |
| Accustem Sciences Inc. | -3.74 Million USD | -71.194% |
| RVL Pharmaceuticals plc | -51.69 Million USD | 87.593% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | -1.26 Million USD | -406.154% |
| Q BioMed Inc. | -2.05 Million USD | -212.542% |
| Emmaus Life Sciences, Inc. | -3.73 Million USD | -71.809% |
| Mosaic ImmunoEngineering Inc. | -2.38 Million USD | -169.383% |
| Biomind Labs Inc. | -1.21 Million USD | -428.168% |
| American Oriental Bioengineering, Inc. | -59.72 Million USD | 89.261% |
| Provectus Biopharmaceuticals, Inc. | -3.1 Million USD | -106.774% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | -7.9 Million USD | 18.846% |
| GlobeStar Therapeutics Corporation | -1.94 Million USD | -229.032% |
| THC Farmaceuticals, Inc. | -14.97 Thousand USD | -42726.175% |
| Acro Biomedical Co., Ltd. | -15.87 Million USD | 59.59% |
| Curative Biotechnology, Inc. | -5.81 Million USD | -10.252% |
| GB Sciences, Inc. | -1.36 Million USD | -371.011% |
| Alpha Cognition Inc. | -13.77 Million USD | 53.432% |
| HST Global, Inc. | -146.21 Thousand USD | -4286.6% |
| CSL Limited | 2.64 Billion USD | 100.243% |
| Wesana Health Holdings Inc. | -1.75 Million USD | -265.498% |
| Halberd Corporation | -79.67 Thousand USD | -7949.661% |
| Enzolytics Inc. | -2.17 Million USD | -194.632% |
| Agentix Corp. | -1.37 Million USD | -366.715% |
| Resverlogix Corp. | -3.61 Million USD | -77.663% |
| Nuo Therapeutics, Inc. | -3.17 Million USD | -102.232% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -295.05 Million USD | 97.826% |
| Enzon Pharmaceuticals, Inc. | 98 Thousand USD | 6644.539% |
| Endonovo Therapeutics, Inc. | 6.92 Million USD | 192.621% |
| RespireRx Pharmaceuticals Inc. | -3.97 Million USD | -61.431% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.02 Million USD | -111.942% |
| Zenith Capital Corp. | -10.59 Million USD | 39.471% |
| Genscript Biotech Corporation | -95.47 Million USD | 93.283% |
| Ember Therapeutics, Inc. | -23.24 Thousand USD | -27495.078% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -4.14 Million USD | -54.697% |
| WPD Pharmaceuticals Inc. | -60.44 Thousand USD | -10511.488% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -219.864% |
| Kadimastem Ltd | -3.3 Million USD | -93.918% |
| Helix BioMedix, Inc. | -1.05 Million USD | -507.32% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -3.81 Million USD | -67.941% |
| BioStem Technologies, Inc. | -8.48 Million USD | 24.394% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -441.36 Thousand USD | -1353.126% |
| LadRx Corporation | 400.44 Thousand USD | 1701.638% |
| Cell Source, Inc. | -5.32 Million USD | -20.53% |
| Regen BioPharma, Inc. | 1.02 Million USD | 726.634% |
| Regen BioPharma, Inc. | 1.02 Million USD | 726.634% |
| NovAccess Global Inc. | -4.76 Million USD | -34.481% |
| Affymax, Inc. | -14.42 Million USD | 55.535% |
| Itoco Inc. | -1.86 Million USD | -243.16% |
| Rasna Therapeutics, Inc. | -4.44 Million USD | -44.369% |
| Pathfinder Cell Therapy, Inc. | -1.66 Million USD | -284.281% |
| Mobile Lads Corp. | -2.26 Million USD | -183.377% |
| CytoDyn Inc. | -49.84 Million USD | 87.132% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.03 Thousand USD | -8015.152% |
| NanoSphere Health Sciences Inc. | -228.12 Thousand USD | -2711.437% |
| Alseres Pharmaceuticals, Inc. | -941.52 Thousand USD | -581.195% |
| SYBLEU INC | -180.3 Thousand USD | -3457.13% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.61 Million USD | -297.687% |
| International Stem Cell Corporation | -131 Thousand USD | -4795.915% |
| Bioxytran, Inc. | -4.28 Million USD | -49.852% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -54.27 Thousand USD | -11717.6% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.53 Million USD | -153.479% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -48.07 Million USD | 86.658% |
| Adhera Therapeutics, Inc. | -2.11 Million USD | -203.389% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -780.88 Thousand USD | -721.329% |
| Innovation Pharmaceuticals Inc. | -3.16 Million USD | -102.451% |
| Neutra Corp. | -233.46 Thousand USD | -2647.156% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | 68.392% |
| PureTech Health plc | -65.69 Million USD | 90.238% |
| Coeptis Therapeutics, Inc. | -21.26 Million USD | 69.842% |
| IXICO plc | -1.17 Million USD | -444.452% |
| IntelGenx Technologies Corp. | -9.92 Million USD | 35.392% |
| Gelesis Holdings, Inc. | -57.12 Million USD | 88.773% |
| CSL Limited | 2.64 Billion USD | 100.243% |
| Cellectis S.A. | -103.17 Million USD | 93.784% |